RedHill Biopharma (RDHL) Intangibles (2011 - 2026)
RedHill Biopharma's Intangibles came in at $5.29 million for the quarter ended Dec 31, 2025, down 4.6% from $5.55 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Intangibles (2011 - 2026) Analysis & Trends
Going back to the quarter ended Dec 31, 2011, RedHill Biopharma's Intangibles data covers 49 quarters.
- Intangibles has declined in each of the last five years, with a five-year compound annual growth rate of -43.0% (years ended Dec 2020 to Dec 2025).
- Going back by year, Intangibles was $5.55 million in the year ended Dec 31, 2024 (-0.6%), $5.58 million in the year ended Dec 31, 2023 (-91.5%), $65.63 million in the year ended Dec 31, 2022 (-8.4%) and $71.64 million in the year ended Dec 31, 2021 (-18.5%).
- The figure for the quarter ended Dec 31, 2025 represents the lowest quarterly Intangibles since the quarter ended Sep 30, 2018.
- The fastest year-over-year change in Intangibles over five years came in the quarter ended Mar 31, 2021 (growth of 442.9%), and the weakest in the quarter ended Mar 31, 2023 (a decline of 92.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | RedHill Biopharma | 7.09 Mn | 7.09 Mn | - | 5.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.29 Mn |
| Dec 31, 2025 | 5.29 Mn |
| Jun 30, 2025 | 5.53 Mn |
| Dec 31, 2024 | 5.55 Mn |
| Jun 30, 2024 | 5.56 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Jun 30, 2023 | 5.59 Mn |
| Mar 31, 2023 | 5.60 Mn |
| Dec 31, 2022 | 65.63 Mn |
| Sep 30, 2022 | 67.14 Mn |
| Jun 30, 2022 | 68.74 Mn |
| Mar 31, 2022 | 70.04 Mn |
| Dec 31, 2021 | 71.64 Mn |
| Sep 30, 2021 | 82.39 Mn |
| Jun 30, 2021 | 84.22 Mn |
| Mar 31, 2021 | 86.05 Mn |
| Dec 31, 2020 | 87.88 Mn |
| Sep 30, 2020 | 89.96 Mn |
| Jun 30, 2020 | 79.52 Mn |
| Mar 31, 2020 | 15.85 Mn |
API Access
RedHill Biopharma Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();